EASDelearning

In the latest episode of our Gamechangers video series, Professor John Buse talks about a paper that he thinks will transform the way we manage #diabetes in years to come. More Gamechangers episodes: easd-elearning.org/horizons/video…

When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes. Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria. 👉 easd-elearning.org/diabetes-in-wa…

We found a disruption to the seasonal pattern but no overall increase in the expected incidence of pediatric diabetes during the first three years of the COVID-19 pandemic in Ontario, Canada. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1…

People with diabetes often encounter stigma which can adversely affect their health. In @TheLancetEndo, authors call on the health community to endorse an evidence-based pledge to proactively challenge, & bring an end to, diabetes stigma & discrimination. hubs.li/Q02dRnmQ0

These data define pathophysiological underpinnings of the tree structure, which has the potential to stratify #diabetes-related complications on the basis of routinely available variables & thereby expand the toolbox of precision diabetes diagnosis thelancet.com/journals/landi… #T2D

5 things we don't yet know...about #diabetes Take a look at our video series with leading researchers talking about the big research questions that still need to be answered. 👉 easd-elearning.org/horizons/video…

🚨🚨🚨Real‐world effectiveness and safety of oral semaglutide in people living with T2D: A nationwide multicentre retrospective observational study (ENDO2S‐RWD) Diabetes, Obesity and Metabolism …ubs.pericles-prod.literatumonline.com/doi/10.1111/do… 🆓 @sociedadSEEN @SENefrologia @secardiologia @SEMERGENap

Psychosocial care for people with diabetic neuropathy needs attention from both clinicians and researchers: a call for action. @ADA_Pubs Read Here➡️doi.org/10.2337/dci23-…

Both continuous and intermittently scanned continuous glucose monitoring provide significant reductions in HbA1c compared to usual care, with no adverse impact on hypoglycemia. @ADA_Pubs Read Here➡️doi.org/10.2337/dc23-1…

In our clip of the week, Professor John Buse discusses the paper that could change the future of screening for type 1 #diabetes. #T1D Full clip on our site: easd-elearning.org/videos/ability…

Our paper Inequalities the management of diabetic kidney disease in UK primary care: A cross‐sectional analysis of a large primary care database - ⁦@idasgupta7⁩ ⁦@Nirantharakumar⁩ ⁦@sribellary⁩ ⁦@m_alikaramat⁩ ⁦@hazlehurst_j⁩ onlinelibrary.wiley.com/doi/10.1111/dm…

When a country faces war or natural disaster, it will face unique challenges in caring for its population with diabetes. Read our report from #EASD2023 on the challenges faced by people with #diabetes in Yemen, Iraq and Syria 👉 easd-elearning.org/diabetes-in-wa…

#GLP1ReceptorAgonists are associated with lower incidences of adverse cardiovascular events and all-cause mortality in individuals with #NAFLD and #type2diabetes, compared with other glucose-lowering medications @DrAKrishnanMD #matchedcohortstudy tinyurl.com/2ef8unpm 🔓

Everything you need when designing a study to investigate hepatic glucose uptake with FDG PET: getting us one step closer to unravelling the relationship between #diabetes and liver glucose metabolism tinyurl.com/2ksp24zv

Meta-analysis 54 RCTs & 32 cohort studies SGLT2 inhibitors significantly ⬇️ MI incidence in RCTs & cohort studies Cardioprotective effects of SGLT2 inhibitors observed in people with and without a history of CVD. Interesting forest plots! dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

‘A blog to show case 10 folks or groups who –in my opinion-deserve a mention for their work which has helped many with #Diabetes through the year’ The “Top 10” for 2023 Thank you from me for all the work you all continue to do in challenging times Link: nhssugardoc.blogspot.com/2023/12/top-te…

Here, the brilliant Patrik Rorsman and team from @ocdem, @SahlgrenskaAcad and @OxfordBRC show the GLP-1 derivative GLP-1(9–36) to possess a direct inhibitory effect on glucagon secretion - an effect that was lost in alpha cells from human donors with #T2D link.springer.com/article/10.100…

Clip of the week: Professor John Buse chooses a gamechanging paper that he thinks will transform the way we manage #diabetes in years to come. Full clip: easd-elearning.org/videos/ability…

Risk Factors for Young-Onset Dementia in the UK Biobank 15 risk factors identified, yep diabetes in there 😉 but a few interesting ones & considerations @kamleshkhunti @scelee1 @ketandhatariya @EASDelearning @AskDrShashank @GoggleDocs @GeriSoc jamanetwork.com/journals/jaman…

New findings from SURPASS were presented at #EASD2023, revealing that tirzepatide comes with some extra benefits. #Diabetes Read our report: easd-elearning.org/tirzepatide-su…